Home » Watchlist Week of August 8th, 2022

Watchlist Week of August 8th, 2022

Krystal Biotech, Inc. (Long Idea)

Again, biotech stocks are showing a lot of strength right now.

Last week, I introduced you to Ionis Pharmaceuticals, Inc. (IONS), which broke out and climbed 16% in just two days.

Krystal Biotech, Inc. (KRYS) is another biotech stock setting up in a similar pattern.

Daily Chart of Krystal Biotech, Inc. (KRYS) – Source: TradingView

KRYS has formed a base over the last eight months and is finally starting to break out into new highs on above-average volume.

With resistance broken and almost no overhead supply, this could be the beginning of a strong rally higher.

Intra-Cellular Therapies, Inc. (Long Idea)

Intra-Cellular Therapies, Inc. (ITCI) is another biotech stock I have been watching for several months.

Daily Chart of Intra-Cellular Therapies, Inc. (ITCI) – Source: TradingView

Many of the companies in this space are pre-revenue. But ITCI is growing sales at triple-digit rates every quarter.

Fund ownership is also ramping up. This is a good sign, as it shows institutional interest (big players) building positions in the stock.

Xenon Pharmaceuticals Inc. (Long Idea)

I have brought your attention to Xenon Pharmaceuticals Inc. (XENE) over the last few months and added it to the Watchlists of several of my research services.

Daily Chart of Xenon Pharmaceuticals Inc. (XENE) – Source: TradingView

As you can see in the chart, price has been consolidating for almost a year to form a beautiful base, with pullbacks shallowing from left to right.

Last week, shares finally breached the $36 level, triggering a nice breakout.

If the breakout holds above the pivot, we could see a lasting move higher.

Brand New Strategy for Profiting from AI Stocks.

There’s a brand-new strategy in 2024 for going after big profits in AI stocks. It has nothing to do with Nvidia, Microsoft, Meta – or any of the big AI stocks the media can’t stop talking about.

It has to do with a fast-moving “backdoor” that has opened in the AI market... A backdoor that could send a very special class of AI stocks rocketing into the stratosphere.

Ross Givens
Ross Givens

I bought my first stock when I was 12 years old. It was Microsoft. I’ve been a registered financial advisor. I’ve worked as a stock broker. I ran a managed fund. I was a Vice President at JP Morgan with Series 7, Series 66 and Series 3 securities licenses. I’ve been featured on Fox Business, CNBC, Bloomberg, and a bunch of other networks. The only thing I enjoy more than making money, is helping YOU make money.

With Ross Givens

Looking for an edge? Ross has the inside scoop on top analysis that will help grow your portfolio.. Receive a new stock opportunity every day and get ready to see your investment SURGE!

Tech stocks are rallying – and Ross Givens’ #1 Tech Stock of the Decade has been making BIG moves you don’t want to miss.

Whats in the Article